---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-306222"
form_type: "8-K"
ticker: "DBVT"
cik: "0001613780"
company_name: "DBV Technologies S.A."
filed_at: "2026-07-16T21:02:04+00:00"
generated_at: "2026-07-16T21:04:07.772022+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# DBV Technologies H1 2026 net loss $98M; BLA submission for peanut patch delayed to Q3 2026

## Summary
- Net loss of $98.0M for H1 2026 vs $69.0M for H1 2025; Q2 net loss $50.4M.
- Cash and equivalents $174.9M as of June 30, 2026, funding into Q3 2027.
- BLA submission for VIASKIN Peanut Patch (ages 4-7) now expected in Q3 2026, previously Q2.
- R&D expenses $64.6M in H1 2026, up from $55.2M, driven by clinical trials and BLA prep.
- SG&A expenses rose to $25.1M from $14.1M due to commercial infrastructure build.

## SEC filing metadata
- accession: 0001193125-26-306222
- form_type: 8-K
- ticker: DBVT
- cik: 0001613780
- company_name: DBV Technologies S.A.
- filed_at: 2026-07-16T21:02:04+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613780/000119312526306222/0001193125-26-306222-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613780/000119312526306222/d156695d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-306222
- JSON: https://secwatch.observer/filing/0001193125-26-306222.json
- Plain text: https://secwatch.observer/filing/0001193125-26-306222.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.